Yusuke Nakamura to T-Lymphocytes, Regulatory
This is a "connection" page, showing publications Yusuke Nakamura has written about T-Lymphocytes, Regulatory.
Connection Strength
0.018
-
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. Cancer Sci. 2010 Feb; 101(2):433-9.
Score: 0.018